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Abstract The segment polarity gene Fused (Fu) encodes a
putative serine–threonine kinase Fu, which has been shown
to play a key role in the Hedgehog signaling pathway of
Drosophila. Human FU (hFU) has been shown to enhance
the activity of Gli transcription factors, targets of the
signaling pathway. However, Fu−/− mice do not show
aberrant embryonic development indicating that mouse Fu
(mFu) is dispensable for Hedgehog signaling until birth. In
order to investigate if there are important differences
between hFU and mFu, we cloned the cDNA, analyzed
expression and tested the ability of mFu to regulate Gli
proteins. Of the tested tissues only brain and testis showed
significant expression. However, in transient overexpres-
sion analyses mFu was able to enhance Gli induced
transcription in a manner similar to hFU. Thus, we turned
to RNAi in order to test if mFu would be important for
Hedgehog signaling after all. In one cell line with reduced
mFu expression the Hedgehog signaling was severely
hampered, indicating that mFu may have a role in
Hedgehog signaling and Gli regulation in some cellular
situations.
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Abbreviations
Ci Cubitus interruptus
FACS Fluorescence assisted cell sorting
Fu Fused
FuFL Full length Fused
GST Glutathione S-transferase
Hh Hedgehog
PBS Phosphate buffered saline
PCR polymerase chain reaction
RNAi RNA interference
RPA Ribonuclease Protection Assay
Shh Sonic Hedgehog
siRNA Small interfering RNA
Sufu Suppressor of Fused
Introduction
Hedgehogs (Hh) are secreted signaling molecules important
for numerous biological processes in developing embryos
of a variety of multicellular organisms from flies to humans
(Hooper and Scott 2005). These proteins are also involved
in several postnatal developmental processes. Furthermore,
aberrant Hedgehog signaling has been linked to numerous
types of cancers and several components of the pathway are
either proto-oncoproteins or tumor suppressors (Hooper and
Scott 2005). The Drosophila segment polarity gene Fused
(Fu) (Preat et al. 1990) is one of the principal constituents
in Hedgehog signal transduction, as activator of the
transcription factor Cubitus interruptus (Ci). The Fused
protein (Fu) is likely to activate the pathway in at least two
different manners. The predominant role of Fu is being an
inhibitor of the Ci inhibitor Sufu. Both fruit fly and
vertebrate Fused proteins contain an N-terminal kinase
domain of approximately 300 residues and a much longer
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C-terminal part with regulatory properties. However,
hitherto there have been no reports of phosphorylation
substrates of Fused. Vertebrate Fu has also been implicated
in the Hedgehog pathway since human FU (hFU) is able to
enhance the gene activator function of the Gli transcription
factors, orthologues of Ci (Murone et al. 2000; Østerlund
et al. 2004; Daoud and Blanchet-Tournier 2005). Most
importantly, a recent paper describes the rescue of lym-
phoma cells by expression of Fu or Gli1 (Dierks et al.
2007). The lymphoma cells were grown in the presence of
cyclopamine (an inhibitor of the upstream pathway initiator
Smo) that induces apoptosis. The apoptotic induction could
be overcome by forced expression of either Fused or Gli1
(Dierks et al. 2007). However, two reports have shown that
Fu−/− mice develop normally until birth, suggesting that Fu
is not a crucial component of the Hedgehog pathway in
mice during embryonic development (Chen et al. 2005;
Merchant et al. 2005). There may be several reasons for this
difference. (1) Redundancy, another component is able to
compensate for the loss of Fu, (2) Fused only belongs to a
branch of the pathway with limited or no influence during
embryogenesis, or (3) Fu is not a component of the
mammalian Hh signaling pathway. In fact it is possible
that mFu is not able to enhance Gli induced transcription in
the way hFU is, though they share 86% sequence identity.
We have previously pointed out that there may be
significant difference between Drosophila and vertebrate
Hh signaling (Østerlund and Kogerman 2006). This
includes differences in the way Fu and Sufu contribute to
the signaling process. The more prominent role of Sufu in
Hh signaling in vertebrates (Cooper et al. 2005; Svärd
et al. 2006), as opposed to its marginal role in Drosophila,
may have changed the demands for its regulation. There-
fore, mFu may have a more peripheral role as a regulator of
Gli proteins. On the other hand, soon after birth the Fu−/−
mice develop brain defects and die within 3 weeks (Chen
et al. 2005; Merchant et al. 2005). This shows that Fu is
potentially active in postnatal brain development, which
may involve Hh signaling.
In order to investigate if there is a significant functional
difference between mouse and human Fu proteins we have
cloned mFu cDNA and analyzed its expression pattern in
mouse tissues. Unlike with hFU, we did not detect
ubiquitous expression of mFu, although the expression
was seen in the same mouse tissues that had shown high
levels of expression in humans. It is thus possible that mFu
is expressed in the same tissues as in humans, albeit at a
lower level. Overexpression analyses in Hedgehog respon-
sive cells show that mFu is able to enhance Gli induced
transcription similar to hFU. Thus, we did mFu silencing by
means of RNA interference in the same cell line. We
obtained two stable transformants and one of them clearly
downregulated the responsiveness to Hh. This observation
provide evidence that mFu may have an important but
limited role in Hedgehog signaling.
Materials and methods
Isolation of mFused
Adult mouse brain and testis cDNA samples (kindly
provided by Dr. Kaia Palm) were used for PCR amplifica-
tion with primer pair 5′-CCCTGGATCTATAGC TCTT-3′
(mFu exon 3′-specific sequence) and 5′-CAACAGTAGG
ACAGTGAAGG-3′ (exon 28-specific sequence) using
Expand Long Template PCR System Kit (Roche Applied
Science, Basel, Switzerland) according to manufacturer’s
instructions. The obtained PCR products (full length (FL)
and short version (Δ6–26)) were purified from agarose gels
using QIAquick Gel Extraction Kit (Qiagen, Valencia CA,
USA) and subcloned into pCR-BluntII-TOPO vector using
the Zero Blunt TOPO PCR Cloning Kit (Invitrogen,
Carlsbad CA, USA).
Generation of cDNA constructs
The Fu cDNAs were subcloned into pCTAP-C (Stratagene,
La Jolla CA, USA) using the EcoRI sites to generate
FuFLpCTAP and Fu(Δ6–26)pCTAP. Fu(K33R)pCTAP
with Lysine 33 substituted by Arginine was generated from
FuFLpCTAP by PCR mutagenesis using Expand Long
Template PCR System kit (Roche) and a pair of primers
carrying the appropriate point mutations. The obtained PCR
product was gel-purified using JETquick Gel Extraction
Spin Kit (Genomed, St. Louis MO, USA). FuFLpCTAP
was digested with Eco52I (Fermentas, Vilnius, Lithuania)
that cuts FuFL at position 765 (corresponding to amino acid
255) and pCTAP before and after MCS. The obtained
restriction fragments encoding the kinase domain (KD) and
C-terminus (CT) of FuFL were gel-purified using JETquick
Gel Extraction Kit (Qiagen) and cloned into the Eco52I
sites of pCTAP vector resulting in FuKDpCTAP and
FuCTpCTAP constructs, respectively. All constructs were
verified by DNA sequencing. A Fu-specific siRNApSUPER
(FupSUPER) construct was generated according to
the pSUPER RNAi System protocol (OligoEngine, Seattle
WA, USA). The sequence for small interfering RNA
(siRNA) was chosen to be specific for the kinase domain




TGCACAATGTTGGGAGGG-3′ (the target sequence of mFu
is underlined, corresponding nucleotides 180–198) were
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annealed with each other and subcloned into pSUPER vector
between BamHI and HindIII sites.
The FL human Gli1EGFP construct is described in
(Kogerman et al. 1999). The translated region of FL mouse
Gli2 was amplified by PCR using pair of oligonucleotides
containing BglII (forward) and BamHI (reverse) restriction
sites and subcloned to pEGFP-C1 vector (Clontech, Palo
Alto CA, USA).
To obtain a ShhC24II encoding construct, the part
encoding residues 25–198 of human Shh was subcloned
into pGEX-6p-2 (Amersham Biosciences, Little Chalfont,
UK). This was achieved by PCR amplification of the
particular part using primes also introducing the restriction
sites BamHI and EcoR1 used for the subcloning. The 5′
primer also introduced an enterokinase cleavage site and
two leucines and the 3′primer introduced a stop codon.
ShhC24II protein purification
The ShhC24II protein is described in (Taylor et al. 2001). The
enterokinase-ShhC24II was expressed as GST-fusion protein
in E. coli strain XL-Blue. Bacteria were lysed by sonication
and the lysate was incubated with Glutathione Sepharose 4B
Fast Flow slurry (Amersham) during 30 min at room
temperature. The enterokinase-ShhC24II protein was
cleaved with enterokinase (Invitrogen) overnight at room
temperature. After cleavage the enterokinase was removed
by EK-away resin (Invitrogen) according to manufacture’s
instructions and ShhC24II was eluted with 1×PBS.
Northern blot
Northern blot analyses were performed as previously
described (Østerlund et al. 2004). Two different cDNA
fragments were chosen: one in the 5′end (nucleotides 216–
768; numbering of nucleotides is from the translational start
site) and another corresponding to exon 26 of the coding
region. These fragments were amplified by PCR and
radioactively labeled with 32P-ATP using the High Prime
DNA labeling kit (Boehringer Mannheim, Manheim,
Germany) according to the manufacturer’s instructions.
The hybridization was performed in ExpressHyb (Clontech)
at 68°C for high specificity, to commercially available
mouse Multiple Tissue Northern blots (Clontech), accord-
ing to the recommendations by the manufacturer.
Ribonuclease Protection Assay (RPA)
Two different riboprobes were synthesized (Fig. 2b).
Sequence of probe 1 corresponded to nucleotides 1–398
of Fu(Δ6–26). Probe 2 was complementary to mFu cDNA
fragment of exon 27 and corresponded to nucleotides
3173–3622 of FuFL or 399–848 of Fu(Δ6–26). Fu(Δ6–
26)Topo construct was cut with NcoI and XbaI (probe 1) or
XbaI and BamHI (probe 2) and obtained cDNA fragments
were subcloned into pTZ57R/T vector (Fermentas) that
contains T7 promoter site in antisense orientation 50 nt down-
stream of the multiple cloning site. Prior to riboprobes
synthesis the constructs were linearized with NcoI (probe 1)
and XbaI (probe 2) and purified by phenol-chloroform
extraction. Linearized mFu templates or pTRI-Actin-Mouse
(0.5 μg) (Ambion, Austin TX, USA) were in vitro translated
using 20 U of T7 RNA polymerase (Fermentas) in the
presence of 15 μCi of (α-32P) UTP (Amersham Biosciences)
at 37°C for 1 h. After translation, the DNA templates were
digested using 10 U of RQ DNaseI (Promega, Madison WI,
USA) at 37°C for 1 h. The probes were phenol-chloroform
purified and diluted in 100 μl of Hybridization III Buffer
(RPA III kit, Ambion). RNA of dissected mouse tissues or
cultured cells was isolated using RNAwiz reagent (Ambion)
according to the manufacturer’s instructions. Total RNA
from each sample (10 μg) was ethanol-precipitated, diluted
in 5 μl of Hybridization III Buffer and mixed with 5 μl of a
radioactively labeled probe. The samples were denatured at
85°C for 10 min and hybridized at 50°C for 16–20 h. Non-
hybridized RNA and free probes were digested with
RNaseA/T1 mix in 100 μl of Digestion III Buffer (Ambion)
for 1 h at 37°C. The reaction was stopped by adding 40 μg
of Proteinase K (Fermentas) in the presence of 0.4% (v/v)
SDS. The non-digested RNA was purified by phenol-
chloroform extraction and resolved on a denaturing 5.5%
acrylamide gel. The gel was dried for 1 h at 80°C.
Radioactive bands were visualized and quantified using a
Bio-Rad GS250 phosphoimager.
Overexpression studies
The NIH-3T3 cell line clone Shh-LIGHT2 (Shh-L2) (Taipale
et al. 2000) was used for the overexpression assay. Shh-L2
cells are stably expressing a Gli-dependent Firefly lucifer-
ase reporter and the Renilla luciferase. The latter was used
for the normalization of data. The cells were propagated in
D-MEM growth medium containing 4500 mg/ml glucose,
supplemented with 10% Fetal Bovine Serum and 5%
penicillin/streptomycin, 0.1 mg/ml zeocin (Invitrogen) and
0.4 mg/ml geneticin (Sigma) at 37°C and 5% CO2.
The cells were seeded at the density 7×104 cells/well on
24-well plates and transfected the next day using Poly-
ethylenimine transfection agent (PEI) (InBio) in ratio PEI:
DNA=1.6 μg: 0.8 μg per well. DNA used for cotransfec-
tion: 0.2 μg of Gli1/Gli2-EGFP and 0.6 μg of different
mFu constructs (or with respective empty vectors). PEI was
mixed with DNA in 50 μl of sterile D-MEM medium for
each well, incubated for 10 min at room temperature and
added to the cells containing 200 μl pr. well of D-MEM.
The cells were transfected for 2 h, after that propagated for
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24 h in the normal growth medium and for additional 24 h
in the Light medium containing 0.5% FBS. Activity was
measured by luciferase assay (see below).
RNA interference of mFu expression
RNA interference (RNAi) of the mFu gene was induced in
Shh-L cell line. The cells were grown as described above
and cotransfected with FupSUPER and pBABE-puro
constructs in ratio 19:1 using (PEI: DNA=17 μg: 5.6 μg
per 10 cm plate). The cells were split 48 h after transfection
and 24 h later the normal growth medium was replaced by
the selective growth medium supplemented with 2 μg/ml of
puromycin. Puromycin-resistant colonies were picked and
propagated in 24-well plates, and eight were chosen for
subsequent analysis. Efficiency of RNAi was verified by
RPA using probe 2. The established cell lines showing
reduced level of mFu mRNA and Shh-L2 as a control were
chosen for further analysis.
The cells were plated at the density 6×104 cells per well
on 24-well plates and were transfected the next day with
0.8 μg per well of pShhNpCMV (Stratagene), GLI1-EGFP
or empty vector pr. well using PEI as described above.
Alternatively the cells were stimulated with the 12 nM
ShhC24II. After 24 h post-transfection or adding of the
ShhC24II, the normal growth medium was replaced with
the Light medium, and cells were incubated for the
additional 24 h prior the Luciferase assay.
Luciferase assay
The cells were rinsed in 1×PBS and lysed in 50 μl of Passive
Lysis Buffer II (Promega). Aliquots of 10 μl were used for the
assay. Firefly and Renilla luciferase activities were measured
using Dual Renilla/Firefly Luciferase kit (Promega) on an
Ascent Fluoroscan luminometer (Thermo Electron Corpora-
tion, Waltham MA, USA) according to manufacturer’s
instructions. All experiments were performed at least 3 times
in 4–6 replicates and the results of representative experiments
are shown with standard deviations.
Results
Identification of two mFu isoforms
A comparative analysis of the mouse genomic and hFU
cDNA sequences revealed the mFused (mFu) gene on
chromosome 1 region C3 (74.90–74.94 kb by Ensembl
annotation (http://www.ensembl.org)) encoding a kinase
known as serine/threonine kinase 36. The mFu gene is
predicted to consist of 28 exons (Merchant et al. 2005)
(Fig. 1a). It contains two 5′UTR exons, translation initiator
codon ATG in exon 3, and Stop codon TAA in exon 28.
Exons 3–9 encode the kinase domain, which is highly
homologous to that of hFU and dFu. The remaining exons
are anticipated to encode parts important for regulatory
functions of Fu (Murone et al. 2000; Østerlund et al. 2004).
Mouse brain and testis cDNAs were chosen for RT-PCR
amplification as those, together with pancreas and the
kidney, were the tissues showing the highest expression of
hFU (Murone et al. 2000; Østerlund et al. 2004). Two PCR
products (Fig. 1b and c) were obtained using a primer pair
complementary to the 19 nt-long unique sequences of the
3rd and 28th exons in the predicted mFu gene. Sequence
analysis revealed that PCR product 1 (FuFL) contained
exons 3–28 of the predicted mFu gene encoding the full-
length (FL) version of Fu (Fig. 1b). The 2nd product –
shorter variant Fu(Δ6–26) – contained exons 3–5 and a part
of exon 6 spliced to exon 27 a few nt from the 5′ splice site
in the FL clone (Fig. 1b).
Sequence analysis predicts a 1,314 residue long FuFL
protein highly homologues to the previously described hFU
protein, showing 97% identity in the kinase domain (N-
terminal 260 residues) and 80% identity in the regulatory
domain. The identity between mFuFL and Drosophila Fu
(dFu) was lower, showing 50 and 10% identity in kinase
and regulatory domain, respectively. The protein encoded
by the Fu(Δ6–26) cDNA clone is 133 amino acids long due
to a Stop codon generated by a frame shift close to the
splicing site in exon 27.
Expression of mFu in brain and testis
The expression pattern of mFu isoforms was analyzed in
different tissues using Northern blot (Fig. 2a) and Ribonu-
clease Protection Assay (RPA) (Fig. 2b and c). The
Northern analyses of adult tissues only revealed an
approximately 5 kb transcript in testis irrespective of the
probe that was used. Also a weak band at 5.5 kb is seen,
suggesting that mFu can encode different mRNA species. It
was not possible to detect any band corresponding to the Fu
(Δ6–26), showing that this is only produced in small
amounts and/or rapidly degraded.
For RPA analyses we used RNA from several adult
mouse tissues and brain at 12 dpc and 1 dpp as well as from
fetal brain at several stages during development. Three
protected fragments were detected using probe 1 (Fig. 2b),
full-length (398 nt) protection specific for Fu(Δ6–26) tran-
scripts (indicated with *) and 323 nt (indicated with **)
plus 76 nt (not shown) bands for mFuFL. The mFuFL was
highly expressed in the testis. Significantly lower levels of
mFuFL were detected in the brain. This expression pattern
of mFuFL was also observed using an mFuFL-specific
probe (3) (data not shown). Fu(Δ6–26) was found only in
testis as a minor alternative transcript.
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Total RNA derived from brain tissue at different stages
of development (E12, E14, E16, E18, P4 and adult) was
analyzed using probe 2 that recognize both FuFL and Fu
(Δ6–26) (Fig. 2c). Expression of mFu was very low on
E12, then gradually increased during embryo brain devel-
opment but decreased after birth.
The mFu protein enhances Gli induced transcription
Human brain and testis are among the tissues with high FU
expression (Murone et al. 2000; Østerlund et al. 2004).
However, hFU mRNA was detected in all tested human
tissues (Murone et al. 2000; Østerlund et al. 2004)
suggesting a functional difference between human and
mouse Fu. We therefore tested if mFu is able to enhance the
transcriptional activity of Gli proteins in a manner similar to
hFU (Murone et al. 2000; Østerlund et al. 2004; Daoud and
Blanchet-Tournier 2005). FuFL and Fu(Δ6–26) were over-
expressed together with Gli proteins and analyzed with
respect to the effect on a Gli responsive firefly luciferase
reporter gene, which is incorporated in the genome of Shh-
LIGHT2 (Shh-L2) cells (Taipale et al. 2000). We also
analyzed the effect of a full kinase domain, the regulatory
domain and a kinase-inactive variant of mFu (the conserved
lysine 33 mutated to arginine (K33R)). The data obtained
were normalized with Renilla luciferase values and the
results of representative experiments are shown (Fig. 3).
Mouse FuFL enhances the transcriptional activity of both
Gli1 and Gli2 approximately four times. The same result
was achieved using mutant Fu(K33R) indicating that the
kinase activity of mFu is not required for the regulation of
Gli-induced transcription. Co-activator potency of Fu(Δ6–
26) was significantly lower, it enhanced the activity of Gli1
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Fig. 1 The structure of mFu
gene and generated cDNA
clones. a The mFu gene found
on Chromosome 1 consists of 28
exons. The translated exons are
3–28 encoding an N-terminal
serine/threonine kinase domain
(exons 3–9; dark gray) and a
C-terminal region (exons 10–28;
light gray) suggested having
regulatory functions. Untrans-
lated parts are shown in black.
b Schematic representation of the
FuFL and Fu(Δ6–26) cDNA
clones obtained by RT-PCR as
shown (arrows) in (c). Compared
to the FuFL cDNA the Fu(Δ6–
26) lacks a big part from exon
6 to 26 indicated by dashed
lines. The different RPA hybrid-
izing probes are also indicated in
(b). Probe 1 consist of 323 nt
before and 76 nt after alternative
splicing in Fu(Δ6–26) giving a
399 nt long protected fragment.
Probe 2 was complimentary to
449 nt of exon 27 present in both
FuFL and Fu(Δ6–26). Probe 3
covers 550 nt from the end of
exon 4 to the middle of exon 7
and is FuFL specific
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the effect of full-length kinase domain of mFu was only
slightly weaker than mFuFL and, moreover, the regulatory
domain of mFu alone could enhance the Gli activity three
times, providing additional evidence that the C-terminal
part of mFu is involved in Gli regulation. Taken together,
our data demonstrate that mFu could enhance the activity of
Gli1 and Gli2 proteins and both the kinase domain and C-
terminal regulatory region of mFu are required for the full
activation of Gli, though the potential kinase activity
appears not to be crucial. These data are similar to those
obtained with hFU (Murone et al. 2000; Østerlund et al.
2004; Daoud and Blanchet-Tournier 2005).
Reduced mFu expression impairs Shh signaling
In the light that mFu and hFU are able to regulate Gli
proteins in the same manner, we wanted to test the
possibility that mFu is of importance for Shh signaling.
To this end we used an RNA interference (RNAi) procedure
to reduce Fu mRNA in Shh-L2 cells. After selection,
several cell lines stably expressing mFu siRNA, were
isolated and verified for RNAi efficiency using RPA
(Fig. 4a). Compared with the control Shh-L cells two cell
lines, Cell line I and Cell line II, showed significant
reduction of mFu mRNA level. Cell line I expressed 35%
and Cell line II only 16% of the Fu mRNA control level
(Fig. 4a). An actin-specific probe was used as control of
expression levels (Fig. 4b). In order to assess the mFu
protein levels in the RNAi cell lines, we employed a novel
mFu affinity purified anti-peptide antibody produced in
rabbits (InBio, Tallinn, Estonia). This antibody was not
highly specific in Western blots, but could be used for
comparison of expression levels of mFu in FACS analysis.
Using this method and the mFu antibody, it could be
determined that Cell line I expresses mFu almost to the
same extent (62%) as control Shh-L2 cells, whereas Cell
line II expresses very low amounts (roughly as low as
background (2%); Fig. 5).
In order to test the ability of the established cell lines to






















































































































































Fig. 2 The mFu expression in
mouse tissues. a Northern blot
analysis of mFu expression in
eight different tissues as indi-
cated. The major 5 kb band is
indicated with a solid arrow and
the minor 5.5 kb band with a
dotted arrow. b RPA expression
analysis of Fu(Δ6–26) (*) and
FuFL (**) using probe 1 in eight
adult tissues and two stages of
brain development. c RPA anal-
ysis of mouse brain at different
developmental stages as indi-
cated (Fused protection indicated
by arrow). b and c Pure water
(mQ) and yeast RNA are used as
negative controls
Fig. 3 Regulation of Gli1 and Gli2 by mFu in Shh-L cells. Different
construct of mFu were overexpressed either alone or together with
either Gli1 or Gli2 in Shh-L cells as shown. Vectors indicate
transfection with empty control vectors and the results were calculated
proportionally to these (=1). Error-bars represent standard deviations
of the calculations
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Shh N-terminal encoding (ShhN)-construct or stimulated
directly with a highly active Shh protein variant (ShhC24II).
Alternatively, luciferase expression was induced directly by
transfection of a Gli1 construct. Activation of luciferase in
the Clone I cells was achieved in all three cases like for
control Shh-L2 cells (Fig. 4c). Cell line II, with lower levels
of Fu mRNA expression, was successfully activated by
Gli1 whereas Shh protein or the ShhN-construct only had
minor effects (Fig. 4c), showing a severely hampered sig-
naling pathway in these cells.
Discussion
In order to investigate the functionality of mFu we have
cloned the cDNA and identified the exons in the genomic
sequences at Ensembl (http://www.ensembl.org). This
corresponds well with the human gene (Østerlund et al.
2004) and the previously published sequences (Chen et al.
2005; Merchant et al. 2005). We did not find the
alternatively spliced variants identified by others (Chen
et al. 2005). Instead, we identified a short variant lacking a
small part of exon 6, exons 7–26 and a small part of exon
27. None of the suggested alternatively spliced variants
(this work and (Chen et al. 2005)) corresponds to the
variants identified in humans (Østerlund et al. 2004). Such
lack of conservation in the pattern of alternative splicing
between species, suggests that alternatively spliced variants
of vertebrate Fu may not play any profound biological
roles. In fact, the short variant identified by us had very
little effect on Gli-induced transcription in our cellular over-
expression assay.
The analyses of expression in adult tissues only show
significant amounts of mFu mRNA in the brain and testis.
This is partly in line with the expression analyses in human
tissues where the highest amounts were found in the brain,
testis, pancreas and kidney (Østerlund et al. 2004).
However, small amounts of hFU mRNA were seen in all
analyzed tissues (Østerlund et al. 2004), which we did not
see in the mouse. In the embryo, mFu was expressed
broadly and the highest expression was detected in the
brain, limbs, the neural tube and somites (Chen et al. 2005).
The high expression of human and mouse Fu in the testis
indicates a prominent role of Fu in this tissue. However, to
assess this issue it is probably necessary to create and
analyze conditional Fu knock-out mice or perhaps examine
the testicular functions of Fu+/− mice.
In order to evaluate the potential role of mFu in the
regulation of Gli proteins, we made overexpression analy-
ses in the NIH3T3 cell clone Shh-L2. Expression of mFuFL
enhanced the activity of Gli1 and Gli2 4-fold. This cor-
responds well with the results obtained with hFU. Human
FU enhances the transcriptional activity of Gli2 in C3H/
10T and HEK293 cells (Murone et al. 2000; Østerlund et al.
Fig. 5 FACS analyses of mFu
RNAi cells. Cell counts of the
two Shh-L2 derived RNAi cell
lines (I and II), of normal Shh-
L2 cells (positive control) and of
medium without cells (negative
control; control) using an mFu
peptide antibody. The percent-
age of Shh-L2 count is given
below
Fig. 4 Analyses of Shh-L clonal cells with reduced mFu mRNA. a RPA
analysis of using probe 2 of control Shh-L cells and two cell lines (I and
II) with significantly lowered mFu expression (Fused protection
indicated by arrow). b Control RPA analysis with actin-specific probe.
As negative controls were used Yeast RNA and water (mQ). The
intensity of the mFu bands was calculated in relation to that actin bands,
showing 35% mFu expression in Cell line I and 16% expression in Cell
line II. c Control Shh-L, Cell line I and II were stimulated by Shh
protein (ShhC24II), by transfection with a Shh construct or by a Gli1
construct. The stimulation of the luciferase reporter is calculated as fold
induction compared to non-stimulated control cells (=1). Error-bars
represent standard deviations of the calculations
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2004) and of GLI1 in NIH3T3C2 and SW480 cells (Daoud
and Blanchet-Tournier 2005) to a similar extent. The
kinase-inactive version of mFu – mFu(K33R) – exhibited
the same effect on Gli activity as the mFuFL which is in
line with results previously demonstrated for the kinase-
inactive variant of hFU (Murone et al. 2000) and a hFU
variant lacking parts of the kinase domain (Østerlund et al.
2004). Taken together, our results are in line with those
previously reported for hFU and both Gli1 and Gli2 are
regulated by mFu variants in a similar way.
The fact that both human and mouse Fu are able to enhance
Gli transcriptional activity suggests that they may influence
Hh signaling. To shed more light on this issue we performed
RNAi analyses in the same Hedgehog responsive cells as we
did the overexpression analyses. Two selected clones showed
significantly lower amounts of mFu mRNA (35 and 16% of
the normal mFu mRNA level, respectively) and the cells with
the lowest expression showed significantly reduced response
to Shh. The fact that the two cell lines show very different
results and that the previous results with mFu RNAi
(Merchant et al. 2005) were similar to those of Cell line I,
led us to speculate that the mFu protein levels may not be
affected significantly until a very low level of mRNA is
reached. Since there were no mFu antibodies available,
which could be used for detection of the protein level, this
was not done in the previous study (Merchant et al. 2005).
Our FACS analyses show that only Cell line II has low mFu
levels and this can explain why only these cells respond
poorly to Shh. It is possible that Cell line I resembles the
previously described Fused RNAi cells (Merchant et al.
2005), although the difference between those cells and our
Cell line II may also reflect differences between the cell lines
dependence on Fused protein for Hedgehog signaling. In our
experiments overexpression of Gli1 served as a positive
control and lead to reporter activation like in the control
cells. These results also suggest that the level of mFu protein
does not follow the RNAi efficiency very well. We conclude
that the actual protein levels must be determined in such
analyses to verify that the protein levels are in fact affected
by the reduction in mRNA.
Mouse embryonic development is not dependent on
mFu, showing that neither is prenatal Hh signaling (Chen
et al. 2005; Merchant et al. 2005). However, in the light
that several reports, including this one, have shown that Fu
is able to enhance Gli-induced gene activation and that
reducing the mFu levels inhibits Shh signaling in the Shh
responsive cells Shh-L2, it is possible that Fu participates in
the Hh pathway by regulating Gli proteins in certain
cellular contexts. For example inhibition of an upstream
pathway component, Smo, by cyclopamine, was overcome
by overexpression of either Fu or Gli1 in lymphoma cells
(Dierks et al. 2007). An intriguing explanation would be
that mammals might exert both Fu-dependent and Fu-
independent Hh signaling, where the latter appears to
dominate in the developing embryo. Other genes may
compensate for the loss of mFu (redundancy) or Fu may be
a component in a branch of the pathway that is of little
importance during embryogenesis. In the light that mFu is
vital for postnatal brain development (Chen et al. 2005;
Merchant et al. 2005), Fu may have a significant role in the
Hh pathway after birth. These results suggest a restricted
but identifiable role of Fu as a regulator of Gli proteins.
Further investigations are required to assess these possibil-
ities and our mFu RNAi Cell line II could be a helpful tool
in this respect. As previously pointed out (Østerlund and
Kogerman 2006), it is possible that Hh signaling is
significantly different between Drosophila and vertebrates.
This may also apply to the way Fu regulates Gli proteins. In
order to fully understand Gli regulation and the Hh
pathway, issues like possible redundancy of Fused-related
proteins, as well as Fu-dependent and Fu-independent Hh
signaling must be addressed.
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